Schroder Investment Management Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $850M | Sell |
1,728,440
-11,462
| -0.7% | -$6.22M | 0.7% | 21 |
|
|
2025
Q4 | $1.01B | Buy |
1,739,902
+14,555
| +0.8% | +$8.23M | 0.76% | 21 |
|
|
2025
Q3 | $837M | Buy |
1,725,347
+113,161
| +7% | +$52.7M | 0.65% | 25 |
|
|
2025
Q2 | $654M | Sell |
1,612,186
-31,597
| -2% | -$13.2M | 0.55% | 32 |
|
|
2025
Q1 | $818M | Sell |
1,643,783
-35,197
| -2% | -$19.1M | 0.83% | 21 |
|
|
2024
Q4 | $873M | Buy |
1,678,980
+69,885
| +4% | +$38.4M | 0.84% | 20 |
|
|
2024
Q3 | $995M | Buy |
1,609,095
+15,951
| +1% | +$9.44M | 1.02% | 15 |
|
|
2024
Q2 | $881M | Buy |
1,593,144
+117,838
| +8% | +$67.5M | 0.97% | 17 |
|
|
2024
Q1 | $857M | Buy |
1,475,306
+169,863
| +13% | +$95.3M | 1.01% | 15 |
|
|
2023
Q4 | $693M | Buy |
1,305,443
+162,538
| +14% | +$78.7M | 0.9% | 19 |
|
|
2023
Q3 | $579M | Buy |
1,142,905
+48,593
| +4% | +$25.9M | 0.86% | 21 |
|
|
2023
Q2 | $571M | Buy |
1,094,312
+3,375
| +0.3% | +$1.82M | 0.82% | 21 |
|
|
2023
Q1 | $629M | Sell |
1,090,937
-63,998
| -6% | -$36.1M | 0.94% | 18 |
|
|
2022
Q4 | $636M | Sell |
1,154,935
-18,380
| -2% | -$9.74M | 1.01% | 17 |
|
|
2022
Q3 | $595M | Buy |
1,173,315
+44,126
| +4% | +$24.7M | 0.98% | 16 |
|
|
2022
Q2 | $613M | Buy |
1,129,189
+69,835
| +7% | +$38.4M | 0.93% | 14 |
|
|
2022
Q1 | $626M | Buy |
1,059,354
+58,654
| +6% | +$33.7M | 0.83% | 18 |
|
|
2021
Q4 | $668M | Buy |
1,000,700
+125,990
| +14% | +$78.7M | 0.87% | 18 |
|
|
2021
Q3 | $500M | Buy |
874,710
+3,021
| +0.3% | +$1.66M | 0.77% | 18 |
|
|
2021
Q2 | $440M | Buy |
871,689
+46,564
| +6% | +$22M | 0.55% | 34 |
|
|
2021
Q1 | $377M | Sell |
825,125
-224,447
| -21% | -$107M | 0.49% | 38 |
|
|
2020
Q4 | $489M | Buy |
1,049,572
+8,461
| +0.8% | +$3.97M | 0.69% | 28 |
|
|
2020
Q3 | $453M | Buy |
1,041,111
+173,431
| +20% | +$71.7M | 0.72% | 23 |
|
|
2020
Q2 | $314M | Sell |
867,680
-5,990
| -0.7% | -$2.01M | 0.57% | 30 |
|
|
2020
Q1 | $266M | Buy |
873,670
+16,711
| +2% | +$5.27M | 0.57% | 32 |
|
|
2019
Q4 | $278M | Sell |
856,959
-279,464
| -25% | -$84.7M | 0.45% | 44 |
|
|
2019
Q3 | $327M | Buy |
1,136,423
+154,204
| +16% | +$44.2M | 0.58% | 34 |
|
|
2019
Q2 | $288M | Buy |
982,219
+25,662
| +3% | +$7.07M | 0.52% | 40 |
|
|
2019
Q1 | $262M | Sell |
956,557
-41,376
| -4% | -$10.3M | 0.47% | 50 |
|
|
2018
Q4 | $223K | Sell |
997,933
-313,953
| -24% | -$73.7M | 0.4% | 47 |
|
|
2018
Q3 | $320M | Buy |
1,311,886
+40,386
| +3% | +$9.29M | 0.55% | 33 |
|
|
2018
Q2 | $261M | Buy |
1,271,500
+56,551
| +5% | +$12M | 0.46% | 41 |
|
|
2018
Q1 | $251M | Buy |
1,214,949
+111,264
| +10% | +$23.4M | 0.43% | 45 |
|
|
2017
Q4 | $210M | Buy |
1,103,685
+242,062
| +28% | +$46.4M | 0.34% | 58 |
|
|
2017
Q3 | $161M | Sell |
861,623
-35,843
| -4% | -$6.49M | 0.28% | 79 |
|
|
2017
Q2 | $156M | Sell |
897,466
-133,919
| -13% | -$22.5M | 0.28% | 78 |
|
|
2017
Q1 | $159M | Sell |
1,031,385
-57,472
| -5% | -$8.78M | 0.29% | 78 |
|
|
2016
Q4 | $154M | Sell |
1,088,857
-392,606
| -27% | -$57.9M | 0.29% | 73 |
|
|
2016
Q3 | $236M | Sell |
1,481,463
-197,590
| -12% | -$30.4M | 0.44% | 43 |
|
|
2016
Q2 | $248M | Buy |
1,679,053
+85,133
| +5% | +$12.6M | 0.5% | 40 |
|
|
2016
Q1 | $224M | Sell |
1,593,920
-19,850
| -1% | -$2.66M | 0.46% | 47 |
|
|
2015
Q4 | $229M | Buy |
1,613,770
+36,326
| +2% | +$4.85M | 0.47% | 41 |
|
|
2015
Q3 | $193M | Sell |
1,577,444
-117,324
| -7% | -$15.3M | 0.41% | 50 |
|
|
2015
Q2 | $219M | Sell |
1,694,768
-62,611
| -4% | -$8.16M | 0.43% | 48 |
|
|
2015
Q1 | $235M | Buy |
1,757,379
+115,714
| +7% | +$14.9M | 0.46% | 42 |
|
|
2014
Q4 | $206M | Buy |
1,641,665
+153,805
| +10% | +$18.7M | 0.4% | 58 |
|
|
2014
Q3 | $181M | Buy |
1,487,860
+441,608
| +42% | +$53.7M | 0.24% | 86 |
|
|
2014
Q2 | $123M | Buy |
1,046,252
+139,367
| +15% | +$16.4M | 0.15% | 129 |
|
|
2014
Q1 | $109M | Buy |
906,885
+10,342
| +1% | +$1.23M | 0.12% | 148 |
|
|
2013
Q4 | $99.8M | Buy |
896,543
+187,171
| +26% | +$18.6M | 0.12% | 143 |
|
|
2013
Q3 | $65.4M | Buy |
709,372
+664,237
| +1,472% | +$60.1M | 0.16% | 162 |
|
|
2013
Q2 | $3.82M | Buy |
+45,135
| New | +$3.76M | 0.01% | 793 |
|
Other funds holding TMO
VCM
Schroder Investment Management Group's TMO Position: Q1 2026 in Review
Schroder Investment Management Group reduced its Thermo Fisher Scientific (TMO) stake by 0.66% in Q1 2026, selling an estimated $6.22M and leaving 1,728,440 shares worth $850M. The position accounts for 0.7% of the portfolio, ranked #21.
Schroder Investment Management Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01B in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Schroder Investment Management Group held 1,728,440 shares of Thermo Fisher Scientific worth $850M as of Q1 2026.
- Schroder Investment Management Group sold 11,462 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.22M.
- Thermo Fisher Scientific made up 0.7% of Schroder Investment Management Group's portfolio in Q1 2026, its #21 holding.
- Schroder Investment Management Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Schroder Investment Management Group's Thermo Fisher Scientific position peaked at $1.01B in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.